Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

291 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treating hyperlipidemia for the primary prevention of coronary disease. Are higher dosages of lovastatin cost-effective?
Perreault S, Hamilton VH, Lavoie F, Grover S. Perreault S, et al. Arch Intern Med. 1998 Feb 23;158(4):375-81. doi: 10.1001/archinte.158.4.375. Arch Intern Med. 1998. PMID: 9487235
A head-to-head comparison of the cost effectiveness of HMG-CoA reductase inhibitors and fibrates in different types of primary hyperlipidemia.
Perreault S, Hamilton VH, Lavoie F, Grover S. Perreault S, et al. Cardiovasc Drugs Ther. 1997 Jan;10(6):787-94. doi: 10.1007/BF00053037. Cardiovasc Drugs Ther. 1997. PMID: 9110123 Clinical Trial.
Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
Perreault S, Dorais M, Coupal L, Paradis G, Joffres MR, Grover SA. Perreault S, et al. CMAJ. 1999 May 18;160(10):1449-55. CMAJ. 1999. PMID: 10352634 Free PMC article.
Efficacy and cost of HMG-CoA reductase inhibitors in the treatment of patients with primary hyperlipidemia.
Perreault S, Levinton C, Le Lorier J. Perreault S, et al. Can J Clin Pharmacol. 2000 Autumn;7(3):144-54. Can J Clin Pharmacol. 2000. PMID: 11044760
Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention.
Perreault S, Blais L, Lamarre D, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J. Perreault S, et al. Br J Clin Pharmacol. 2005 May;59(5):564-73. doi: 10.1111/j.1365-2125.2005.02355.x. Br J Clin Pharmacol. 2005. PMID: 15842555 Free PMC article.
Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease.
Perreault S, Blais L, Dragomir A, Bouchard MH, Lalonde L, Laurier C, Collin J. Perreault S, et al. Eur J Clin Pharmacol. 2005 Oct;61(9):667-74. doi: 10.1007/s00228-005-0980-z. Epub 2005 Oct 19. Eur J Clin Pharmacol. 2005. PMID: 16151763
Impact of adherence to statins on coronary artery disease in primary prevention.
Bouchard MH, Dragomir A, Blais L, BĂ©rard A, Pilon D, Perreault S. Bouchard MH, et al. Among authors: perreault s. Br J Clin Pharmacol. 2007 Jun;63(6):698-708. doi: 10.1111/j.1365-2125.2006.02828.x. Epub 2007 Jan 3. Br J Clin Pharmacol. 2007. PMID: 17214831 Free PMC article.
Comparison of persistence rates with angiotensin-converting enzyme inhibitors used in secondary and primary prevention of cardiovascular disease.
Gogovor A, Dragomir A, Savoie M, Perreault S. Gogovor A, et al. Among authors: perreault s. Value Health. 2007 Sep-Oct;10(5):431-41. doi: 10.1111/j.1524-4733.2007.00247.x. Value Health. 2007. PMID: 17888108
Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women.
Blouin J, Dragomir A, Moride Y, Ste-Marie LG, Fernandes JC, Perreault S. Blouin J, et al. Among authors: perreault s. Br J Clin Pharmacol. 2008 Jul;66(1):117-27. doi: 10.1111/j.1365-2125.2008.03178.x. Epub 2008 May 6. Br J Clin Pharmacol. 2008. PMID: 18460036 Free PMC article.
Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial.
Lalonde L, Martineau J, Blais N, Montigny M, Ginsberg J, Fournier M, Berbiche D, Vanier MC, Blais L, Perreault S, Rodrigues I. Lalonde L, et al. Among authors: perreault s. Am Heart J. 2008 Jul;156(1):148-54. doi: 10.1016/j.ahj.2008.02.009. Epub 2008 Jun 3. Am Heart J. 2008. PMID: 18585510 Clinical Trial.
291 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback